menu
    • menu

    Company profile for Upstream Bio

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Upstream Bio is a biotech company that strives to reach the source of inflammation and conquer it. The company's lead program is a clinical-stage monoclonal antibody that inhibits the TSLP receptor which is a validated target positioned upstream of multiple signaling cascades that affect a variety of immune cells pivotal to common and rare diseases, allowing medical professionals to ease the burden of inflammatory and allergic...
    Upstream Bio is a biotech company that strives to reach the source of inflammation and conquer it. The company's lead program is a clinical-stage monoclonal antibody that inhibits the TSLP receptor which is a validated target positioned upstream of multiple signaling cascades that affect a variety of immune cells pivotal to common and rare diseases, allowing medical professionals to ease the burden of inflammatory and allergic diseases with novel therapeutics on patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Upstream BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    460 Totten Pond Rd. Suite 420 Waltham, MA 02451
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.upstreambio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/upstreambio
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/UpstreamBio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Upstream Bio To Unveil Phase 2 Verekitug Data At ATS 2026
    Upstream Bio To Unveil Phase 2 Verekitug Data At ATS 2026

    19 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7187519

    FIRSTWORD PHARMA
    19 Apr 2026
    Share Share
    Upstream Bio Shares Verekitug Ph3 Plan, FY25 Results
    Upstream Bio Shares Verekitug Ph3 Plan, FY25 Results

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3262866/0/en/Upstream-Bio-Highlights-Phase-3-Development-Strategy-for-Verekitug-and-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Upstream Bio Unveils Verekitug Phase 2 VIBRANT Trial Data
    Upstream Bio Unveils Verekitug Phase 2 VIBRANT Trial Data

    01 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/01/3246934/0/en/Upstream-Bio-Presents-Additional-Analyses-from-the-Phase-2-VIBRANT-Trial-of-Verekitug-in-Chronic-Rhinosinusitis-with-Nasal-Polyps-at-2026-AAAAI-Annual-Meeting.html

    GLOBENEWSWIRE
    01 Mar 2026
    Share Share
    Upstream Bio Presents VIBRANT CRSwNP Data at AAAAI 2026
    Upstream Bio Presents VIBRANT CRSwNP Data at AAAAI 2026

    26 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/26/3245409/0/en/Upstream-Bio-to-Present-Additional-Analyses-from-Phase-2-VIBRANT-Trial-in-Chronic-Rhinosinusitis-with-Nasal-Polyps-in-Late-Breaking-Session-at-AAAAI-Annual-Meeting-2026.html

    GLOBENEWSWIRE
    26 Feb 2026
    Share Share
    Upstream Bio To Join March Investor Conference
    Upstream Bio To Join March Investor Conference

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244446/0/en/Upstream-Bio-to-Participate-in-Upcoming-March-Investor-Conferences.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    Upstream Posts Tezspire-like Asthma Efficacy in phase 2
    Upstream Posts Tezspire-like Asthma Efficacy in phase 2

    12 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/upstream-posts-tezspire-asthma-efficacy-phase-2-falls-short-best-case-scenario

    FIERCE BIOTECH
    12 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search